President Trump urged pharmaceutical companies to reduce their drug prices within a month to align more closely with those in other wealthy nations, warning that failure to comply could result in strict limits on their Medicare earnings, indicating that the pharmaceutical industry is not out of the hot seat says Cornell University professor Colleen Carey. 

Law and Policy

---

Colleen Carey, an expert health care economics and federal regulations of health care policy, says vaccine developers will likely follow FDA guidance despite the White House’s efforts to block it.

Life Sciences & Veterinary Medicine

---

Colleen Carey, professor of policy analysis and management, says President-elect Biden may be in a strange position with the pharmaceutical industry come January, as President Trump pursued policies unfavorable to pharmaceutical companies, even as those same companies drive the development of a coronavirus vaccine.

Law and Policy

---

Cornell experts are available to discuss the potential of a coronavirus vaccine from multiple angles, including the science of vaccines, why people choose not to be vaccinated, health care systems, insurance companies and policies. 

Life Sciences & Veterinary Medicine

---